International S.c.a. Artal is Director & 10% Owner at LEXICON PHARMACEUTICALS, INC. (LXRX). They have made 5 open-market trades across 2 companies since 2014, most recently 2026-02-17.
CIK 0001218180
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
4 open-market purchases totalling $82.7M since 2014, against 1 sale. Too few scored purchases to measure a record yet.
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| LXRX | BUY | 2022-08-05 | 2022-08-09 | $2.50 | $6.1M | +15.8% | +7.5% | -19.6% |
| LXRX | BUY | 2022-08-01 | 2022-08-01 | $2.50 | $40.4M | +8.2% | +7.8% | -15.7% |
| LXRX | BUY | 2020-12-16 | 2020-12-17 | $3.20 | $35.0M | -5.4% | +126.7% | +88.3% |
| WTW | SELL | 2018-08-14 | 2018-08-16 | $76.00 | $456.0M | -0.6% | -1.6% | +7.4% |
| WTW | BUY | 2014-08-15 | 2014-08-19 | $23.36 | $1.2M | -7.3% | +2.0% | +2.0% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.